Arthur Allen, Jean Connors, Stephan Moll and Naomi Yates Explore Key Findings from The RENOVE and APICAT Trials
Anticoagulation Forum shared an inviting post on LinkedIn:
”Just 2 days away! Don’t miss our upcoming webinar: Secondary VTE Prevention: To Reduce or Not to Reduce?
Thursday, August 7 | 12:00 PM ET
We are excited to welcome another expert to our panel: Naomi Yates, PharmD, BCACP, who will join as a moderator to help guide this dynamic conversation on one of the most debated questions in anticoagulation: what’s the right dose, and when should it be reduced?
This live webinar will explore key findings from the RENOVE and API-CAT trials, framed by a historical lens and brought to life by a panel of expert clinicians.
What you’ll learn:
- DOAC dosing strategies for extended secondary VTE prevention
- Evidence-based guidance for individualizing care
- Practical takeaways for real-world treatment
Speakers:
Arthur Allen, PharmD, CACP
Jean Connors, MD
Stephan Moll, MD
Naomi Yates, PharmD, BCACP
There’s still time to register and bring your clinical questions to the panel.”
Register here.
Stay updated on all conferences, webinars and panel discussions on coagulation disorders with Hemostasis Today.
-
Aug 25, 2026, 07:28Manuel Monreal: VTE and Severe Renal Insufficiency – What Does RIETE Tell Us?
-
Aug 25, 2026, 07:26Tom B.: Platelet Transfusion as a Potential Mitochondrial Therapy for Sepsis
-
Aug 25, 2026, 07:20Scott McInnes: Giving Blood When the Need Is Greater Than Ever
-
Aug 25, 2026, 06:10Shiny K. Kajal: Rh Is More Than Just Positive or Negative
-
Aug 25, 2026, 00:07Muhammad Ali Khan: Using EHR Data to Predict Fibrotic Progression in PV and ET
-
Aug 25, 2026, 00:06Michael R. Scoma: The Vascular Dimension of Long COVID
-
Aug 24, 2026, 23:40Vimee Bindra: Your Period May Be Trying to Tell You Something
-
Aug 24, 2026, 23:30R. P. Singh: Hemophilia and HIV Relationship
-
Aug 24, 2026, 23:12Marta Velia Antonini: Hemolysis in ECMO – More Than Just a Laboratory Finding